Author: Ravi Shankar

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS

Neuberger Private Equity Partners Announces Transaction in Own Shares

St Peter Port, Guernsey 24 September 2026

Neuberger Private Equity Partners Limited (“NBPE” or the “Company”) today announces details of Class A Shares bought back pursuant to general authority granted by shareholders of the Company on 11 June 2026 and the share buy-back agreement with Jefferies International Limited.

Transaction on London Stock Exchange

Date of purchase of Shares	23 September 2026
Number of Shares purchased	95,793 Class A Shares
Highest price/lowest price paid	£14.58 / £14.54
ISIN for the Shares	GG00B1ZBD492

All Class A Shares bought back will be cancelled. Following the cancellation, the number of outstanding Class A Shares is 37,765,491‬. The Company also has 3,150,408 Class A shares held in treasury. For reporting purposes under the FCA’s Disclosure Guidance and Transparency Rules the market should use the figure of 37,765,491 voting rights when determining if they are required to notify their interest in, or a change to their interest in the Company.

For further information, please contact:

NBPE Investor Relations        +44 20 3214 9002
Luke Mason        NBPrivateMarketsIR@nb.com

Oak Group        +44 1481 723450

        NBPEP@oak.group

About Neuberger Private Equity Partners Limited

Neuberger Private Equity Partners Limited (“NBPE”) invests in direct private equity investments alongside market leading private equity firms globally. NB Alternatives Advisers LLC (the “Investment Manager”), an indirect wholly owned subsidiary of Neuberger Berman Group LLC, is responsible for sourcing, execution and management of NBPE. The vast majority of direct investments are made with no management fee / no carried interest payable to third-party GPs, offering greater fee efficiency than other listed private equity companies. NBPE seeks capital appreciation through growth in net asset value over time while paying a bi-annual dividend.

LEI number: 213800UJH93NH8IOFQ77

About Neuberger

Neuberger was founded in 1939 to do one thing: deliver compelling investment results for our clients over the long term. This remains our singular purpose today, driven by a culture rooted in deep fundamental research, the pursuit of investment insight and continuous innovation on behalf of clients, and facilitated by the free exchange of ideas across the organization.

From offices in 39 cities[1] across 26 countries, Neuberger manages a range of equity, fixed income, private equity and hedge fund strategies on behalf of institutions, advisors and individual investors worldwide. With more than 780[1] investment professionals and over 2,900[1] employees in total, Neuberger has built a diverse team of individuals united in their commitment to client outcomes and investment excellence. Our culture has afforded us enviable retention rates among our senior investment staff and we are proud to have been ranked 1st by Pensions & Investments in their 2025 “Best Places to Work in Money Management” survey, where we have placed 1st in four of the last five years and finished in the top two for 12 consecutive years[2].

As a private, independent, employee-owned investment manager, Neuberger is structurally aligned with the long-term interests of our clients. We have no external parent or public shareholders to serve, nor other lines of business to distract us from our core mission. And with our employees and their families invested alongside our clients—plus 100% of employee deferred cash compensation directly linked to team and firm strategies—we are truly in this together.
For more information, please visit our website: www.nb.com/en/global/who-we-are.

Media Contacts:
US: Soogyung Jordan: Soogyung.Jordan@nb.com
EMEA: Fiona Kehily: Fiona.Kehily@nb.com

[1] Firm data reflects the collective data for the various subsidiaries of Neuberger Berman Group LLC as of 30 June 2026.

[2] Among organizations with over 1,000 employees by Pensions & Investments. For additional information on the criteria for the award, please visit https://www.pionline.com/awards/best-places-to-work-in-money-management/pi-best-places-to-work-2025.

This material is issued on a limited basis through various global subsidiaries and affiliates of Neuberger Berman Group LLC. Please visit www.nb.com/disclosure-global-communications to learn about each company and the legal restrictions and restrictions. The name “Neuberger Berman” and logo are registered service marks of Neuberger Berman Group LLC.

© 2026 Neuberger Berman Group LLC. All rights reserved.

This press release appears as a matter of record only and does not constitute an offer to sell or a solicitation of an offer to purchase any security.

NBPE is established as a closed-end investment company domiciled in Guernsey. NBPE has received the necessary consent of the Guernsey Financial Services Commission. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. This document is not intended to constitute legal, tax or accounting advice or investment recommendations. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. Statements contained in this document that are not historical facts are based on current expectations, estimates, projections, opinions and beliefs of NBPE’s investment manager. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. Additionally, this document contains “forward-looking statements.” Actual events or results or the actual performance of NBPE may differ materially from those reflected or contemplated in such targets or forward-looking statements.

On 16 September 2026, the Minister of Finance, acting on behalf of the Republic of Estonia as the sole shareholder of Eesti Energia AS, approved the new wording of the Company’s Articles of Association and instructed the Management Board to submit it for registration with the Estonian Commercial Register.

The amendments were made to implement mandatory requirements introduced by the amended State Assets Act, which entered into force in June 2026. Compared to the Articles of Association approved on 28 January 2026, the following changes were made:

• Added the shareholder’s right to review documents related to the activities of the Company’s Supervisory Board and internal audit (new clause 9.4);
• Amended and clarified the regulation governing the presentation and disclosure of the annual report and the Supervisory Board’s overview of its activities (clauses 10.2 and 10.4(d));
• Amended the regulation on disclosure of quarterly financial data and added a requirement to disclose a quarterly overview of business activities within two months of the end of each quarter (clause 10.4(b));
• Clarified the title of Chapter 11 to include a reference to the financial plan.

Further Information:

Danel Freiberg
Head of Treasury and Financial Risk Management
Eesti Energia AS
Tel: +372 5594 3838
Email: danel.freiberg@enefit.com

AB “Ignitis grupė” (hereinafter – the Group) informs that its Supervisory Board (hereinafter – the Supervisory Board), following a public selection process, approved Vytenis Koryzna as the final candidate for the position of Chair of the Management Board and CEO of the Group.

V. Koryzna is currently a member of the Management Board and Chief Commercial Officer (CCO) of the Group. He will succeed the Group‘s Chair of the Management Board and CEO Darius Maikštėnas, upon the conclusion of his second term of office on 28 February 2027. The final decision on the election of V. Koryzna for the position of Chair of the Management Board and CEO of the Group will be made after receiving the results of the background checks carried out by the competent authorities on the candidate’s suitability for the position in accordance with the procedure established by applicable legislation. Following the final decision on the election of V. Koryzna, the Supervisory Board will decide on the selection of a new member of the Management Board.

“The Group has undergone an exceptional transformation and today stands as a stronger, strategically well-positioned company, with very solid foundations for the future. The next CEO will inherit that legacy and have the responsibility to build on it. As the energy transition becomes more complex, this next phase will require not only continued investment and growth, but increasingly disciplined execution, operational excellence, and the ability to adapt to a rapidly changing energy environment. We were therefore looking for a leader with the strategic perspective, experience and leadership qualities to take what has been successfully built to the next level, while continuing to develop our people and organisation. We believe that Vytenis can lead Ignitis Group through this next phase, creating sustainable long-term value for our customers, shareholders and the society,” said Alfonso Faubel, Chair of the Supervisory Board of Ignitis Group.

V. Koryzna has more than ten years of senior executive leadership experience, including renewable energy and business transformation. Throughout his career, he has developed energy management, supply, trading and generation businesses, as well as new energy solutions, including solar energy, battery energy storage systems and electric vehicle charging infrastructure. V. Koryzna holds an EMBA in business administration and management from the Baltic Management Institute, and a Master of International Business from Vilnius University.

As a Member of the Board and CCO of the Group, V. Koryzna is responsible for energy markets and commercial operations, the Group’s energy trading, customer and energy solutions, and for building a customer and value-oriented organisation across all the Group’s home markets. V. Koryzna has gained valuable governance experience and an in-depth understanding of the Group’s operations and strategic priorities through his service on the boards of “Ignitis Renewables” and “Ignitis Gamyba”, as well as through chairing the board of “Ignitis”. V. Koryzna also initiated the transformation of the Group’s energy innovation function and the establishment of the Energy Transformation unit. This unit brings together capabilities in energy market analysis and modelling, the development of new technologies, and the creation of smart commercial solutions to further shape the strategy of the Group.

The selection process for the position of Chair of the Management Board and CEO of the Group has been launched on 1 June 2026 (link). The executive search agency UAB “Pedersen & Partners” carried out a comparative assessment of the candidates’ qualifications against the pre-established and publicly announced requirements, in line with best international practices for senior executive search, ensuring sufficient time to identify the strongest candidate.

The group’s CEO is being appointed for a five-year term. According to the requirements of the Description of the Corporate Governance Guidelines of the State-Owned Group of Energy Companies, the Chair of the Management Board of the Group is the CEO of the Group.

Communications
Valdas Lopeta
+370 621 77993
valdas.lopeta@ignitis.lt

Status update on the project to adapt and strengthen
the Casino Group financial structure

Paris, 24 September 2026

Casino Group announces that discussions are continuing with the various stakeholders with a view to reaching a consensual solution leading to the amendment of the safeguard plans of the Group’s entities concerned.

As part of these discussions, there are no plans to provide for interest payments on the TLB debt on their due date at the end of September, Casino Group has deposited the amount payable in respect thereof (€65 million) in a dedicated account, pending the outcome of (i) the plans amendment proceedings and (ii) the action for termination of the plan initiated by the TLB creditors on 6 August 2026¹.

***

ANALYSTS AND INVESTORS CONTACTS

Charlotte IZABEL – cizabel@groupe-casino.fr – Tel: +33 (0)6 89 19 88 33

IR_Casino@groupe-casino.fr – Tel: +33 (0)1 53 65 24 17

PRESS CONTACTS

Casino Group – Communications Department

Stéphanie ABADIE – sabadie@groupe-casino.fr – Tel: +33 (0)6 26 27 37 05

directiondelacommunication@groupe-casino.fr – Tel: + 33(0) 1 53 65 24 29

---

1 Press release dated 7 August 2026

Attachment

• 2026-09-24 – PR – Casino Communication

TR-1: Standard form for notification of major holdings

1. Issuer Details
ISIN
GB00BL6K5J42
Issuer Name
ENDEAVOUR MINING PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Van Eck Associates Corporation
City of registered office (if applicable)
New York
Country of registered office (if applicable)
United States
4. Details of the shareholder

Name	City of registered office	Country of registered office
VanEck Gold Miners ETF
VanEck Natural Resources ETF
VanEck Junior Gold Miners UCITS ETF
VanEck Junior Gold Miners ETF
VanEck S&P Global Mining UCITS ETF
VanEck MSCI International Quality ETF
VanEck Gold Miners ETF
VanEck Gold Miners UCITS ETF
VanEck Africa Index ETF

5. Date on which the threshold was crossed or reached
18-Sep-2026
6. Date on which Issuer notified
22-Sep-2026
7. Total positions of person(s) subject to the notification obligation

.	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	6.975666	0.000000	6.975666	16857062
Position of previous notification (if applicable)	7.000000	0.000000	7.000000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB00BL6K5J42	16857062		6.975666
Sub Total 8.A	16857062		6.975666%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Van Eck Associates Corporation	VanEck Gold Miners ETF	2.440480		2.440480%
Van Eck Associates Corporation	VanEck Natural Resources ETF	0.004850		0.004850%
Van Eck Associates Corporation	VanEck Gold Miners ETF AU	0.101260		0.101260%
Van Eck Associates Corporation	VanEck Gold Miners UCITS ETF	0.386520		0.386520%
Van Eck Associates Corporation	VanEck Africa Index ETF	0.023830		0.023830%
Van Eck Associates Corporation	VanEck Junior Gold Miners ETF	3.394680		3.394680%
Van Eck Associates Corporation	VanEck S&P Global Mining UCITS ETF	0.098780		0.098780%
Van Eck Associates Corporation	VanEck Junior Gold Miners UCITS ETF	0.510350		0.510350%
Van Eck Associates Corporation	VanEck MSCI International Quality ETF	0.014870		0.014870%

10. In case of proxy voting
Name of the proxy holder
Glass Lewis
The number and % of voting rights held
16,857,062 shares and 6.98% voting rights
The date until which the voting rights will be held

If date does not apply, explain below
Open
11. Additional Information

12. Date of Completion
22-Sep-2026
13. Place Of Completion
Tampa, FL, USA

Attachment

• 00814705_TR1_notification

• 19 % reduction in operating expenses compared with the first half of 2025, reflecting the financial discipline of the Group
• Solid cash position of €48 million as of June 30, 2026, enabling Carbios to cover its operating expenses beyond the next 12 months
• Progress in the financing of the Longlaville plant project:
  • Credit committee approvals obtained during the summer from the majority of the project’s lenders
  • Commercial agreement currently being finalized with a major player in the beverage industry, which is expected to increase the plant’s pre-sales level to 60% of its nominal capacity
  • Ongoing due diligence by export credit agencies and equity partners

Clermont-Ferrand (France), 24 September 2026 (7:45 a.m. CEST). Carbios (Euronext Growth Paris: ALCRB) today reports its first-half 2026 financial results, as approved by the Board of Directors on September 23, 2026, and provides an update on its strategic priorities.

Benoît GRENOT, CEO of Carbios, commented: “The results for the first half of 2026 reflect the benefits of the financial discipline implemented since more than a year ago. In parallel, we have reached key milestones in the financing of the Longlaville plant, notably through credit committee approvals from several banking partners and continued progress in securing pre-sales commitments. Looking ahead, our roadmap is clear: finalize this financing and resume construction of the Longlaville plant, further advance our strategic partnership with Wankai, and accelerate the commercialization of our technology, while maintaining rigorous management of our resources.”

1.   Financial results

During the first half of 2026, Carbios continued to execute its cost-control plan launched more than a year ago. Operating expenses decreased by €3.4 million, representing a 19% reduction compared with the first half of 2025. All expenditures were reviewed and optimized to ensure that the Group’s resources remain focused on its strategic priorities.

For the six months ended June 30, 2026, operating loss amounted to €11.8 million, improving by
€3.9 million compared with the first half of 2025.

Net loss came to €9.4 million, compared with €11.9 million in the first half of 2025, reflecting an improvement of €2.5 million.

Carbios SA’s net cash consumption was limited to €4.2 million during the first half of 2026, compared with €33.4 million during the same period in 2025, reflecting the impact of the cost-reduction measures and investment cuts implemented:

• Cash consumption during the period was reduced by €8.3 million in operating activities and by nearly €14 million in investing activities compared with the first half of 2025.
• In addition, Carbios SA received a partial repayment of €8 million on the shareholder loan from its subsidiary Carbios 54.

At Group level, cash consumption amounted to €11 million, compared with €18 million in the same period of the previous year. This financial discipline contributed to maintaining a solid cash position of €48 million as of June 30, 2026, enabling Carbios to cover its operating expenses beyond the next 12 months.

For the second half of 2026, Carbios intends to continue its cost-control efforts while maintaining the resources required to execute its strategic priorities.

2.   Update on the financing of the Longlaville plant project

Over recent months, Carbios has achieved several important milestones in the financing of its Longlaville plant project.

These key developments include:

• the completion of independent reviews covering the project’s technical, economic, environmental and legal aspects, which confirm both its economic viability and the relevance of its location in France;
• the approval of the credit committees of a majority of the project’s lenders;
• a commercial agreement currently being finalized with a major player in the beverage industry, which is expected to increase the plant’s pre-sales level to 60% of its nominal capacity; and
• the validation of the “fiber-to-fiber” biorecycling process, broadening the addressable customer base for the Longlaville plant.

As of today, due diligence activities conducted by export credit agencies¹ and equity partners remain underway. The implementation of the financing is progressing through a necessarily extensive process, reflecting the innovative nature of this large-scale project.

3.   Strategic partnership with Wankai

Since the beginning of 2026, the Company has initiated the operational implementation of the strategic partnership signed with Wankai New Materials on December 2, 2025, notably through the establishment of the Kaibio Biotechnology Co. Ltd joint venture, which will be responsible for constructing the licensed industrial facility, and through qualification tests that confirmed the compatibility of locally available feedstocks and waste streams with the Carbios process.

4.   Licensing for the Packaging and Textiles markets

During the first half of the year, Carbios further strengthened the technological maturity of its PET biorecycling solution by validating its application to the treatment of complex textile waste². This milestone enables the Company to expand its licensing offering to the global textile market, in addition to packaging. In this context, the Company is pursuing discussions internationally with a view to granting additional licenses and accelerating the commercial deployment of its technology.

5.   Changes in Governance

On May 18, 2026³, the Company announced the appointment of Benoît Grenot, then Deputy Chief Executive Officer, as Chief Executive Officer, effective June 1, 2026, succeeding Vincent Kamel.

On July 30, 2026, the Board of Directors appointed Samir Karoum as an independent director by co-optation, replacing Karine Auclair who had resigned, for the remainder of her term of office. The ratification of this appointment will be submitted for approval at the Company’s next General Meeting.

6.   Availability of the 2026 half-year financial report

The 2026 half-year financial report will be made available on Carbios’ website no later than September 30, 2026.

###

About Carbios:

Carbios is a biotechnology company that develops and industrializes biological solutions to reinvent the lifecycle of plastics and textiles. Inspired by nature, Carbios designs enzyme-based biological processes to break down plastics, with the mission of preventing plastic and textile pollution and accelerating the transition to a circular economy. Its two innovative technologies—dedicated to PET biorecycling and PLA biodegradation—are currently scaling up to industrial and commercial levels. Carbios is supported by prestigious brands in the cosmetics, food, and apparel industries, aiming to improve the recyclability and circularity of their products. Nestlé Waters, PepsiCo, and Suntory Beverage & Food Europe took part in a packaging consortium founded by Carbios and L’Oréal. On, Patagonia, PUMA, PVH Corp., and Salomon collaborate with Carbios in a textile consortium. Carbios is part of the global community of B Corp™ certified companies that are transforming their business models to serve the common good.

Visit www.carbios.com to learn more about biotechnology for circular plastics and textiles.

LinkedIn : carbios / Instagram  

Information on Carbios shares:

ISIN Code              FR0011648716
Ticker Code          Euronext Growth: ALCRB
LEI                         969500M2RCIWO4NO5F08

Carbios is eligible for the PEA-PME, a government program allowing French residents investing in SMEs to benefit from income tax rebates.

Disclaimer on forward-looking statements and risk factors:
This press release contains forward-looking statements, not historical data, and should not be construed as a guarantee that the facts and data stated will occur. These forward-looking statements are based on data, assumptions and estimates considered reasonable by Carbios. Carbios operates in a competitive and rapidly evolving environment. It is therefore not in a position to anticipate all risks, uncertainties or other factors that may affect its business, their potential impact on its business or the extent to which the materialization of a risk or combination of risks could lead to results that differ significantly from those mentioned in any forward-looking statement. Carbios draws your attention to the fact that forward-looking statements are in no way a guarantee of its future performance and that its actual financial position, results, cash flows, its partnerships and corporate agreements, and the development of the sector in which Carbios operates may differ significantly from those proposed or suggested by the forward-looking statements contained in this document. In addition, even if Carbios’ financial position, results, cash flows, its partnerships and corporate agreements, and developments in the industry in which it operates are consistent with the forward-looking information contained in this document, such results or developments may not be a reliable indication of Carbios’ future results or developments. Readers are also advised to carefully consider the risk factors described in the Universal Registration Document filed with the French Financial Markets Authority (“AMF”) and made available free of charge on the Company’s website. Should all or any part of these risk factors occur or others, in no case whatsoever will Carbios be liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or for any related damages. This information is given only as of the date of this press release. Carbios makes no commitment to publish updates to this information or on the assumptions on which it is based, except in accordance with any legal or regulatory obligation applicable to it.

For additional information, please contact:

CARBIOS Laura Perrin Communication laura.perrin@carbios.com +33 (0)6 46 44 04 79

CARBIOS Benjamin Audebert Investor Relations contact@carbios.com +33 (0)4 73 86 51 76

Maarc – Press Relations Bruno Arabian bruno.arabian@maarc.fr +33 (0)6 87 88 47 26 Simon Dulucq Simon.dulucq@maarc.fr +33 (0) 6 10 98 55 64

APPENDIX

Carbios SA simplified Income statement:

Income Statement (In thousands of euros)	06/30/2026	06/30/2025
Operating revenues	2 593	2 143
Part of re-invoicing and contracts concluded with CARBIOLICE	292	384
Part of re-invoicing and contracts concluded with CARBIOS 54	838	79
Operating expenses	14 352	17 790
OPERATING INCOME/LOSS	-11 759	-15 647
Financing Income/Loss	1 669	3 202
CURRENT INCOME/LOSS BEFORE TAX	-10 091	-12 445
Extraordinary profit	0	0
Income Tax	-661	-550
Net Income/Loss	-9 429	-11 895

Carbios SA simplified balance sheet:

ASSETS (In thousands of euros)	06/30/2026	12/31/2025		EQUITY AND LIABILITIES (In thousands of euros)	06/30/2026	12/31/2025
Subscribed capital not called up (I)	0	0		Share capital	11 834	11 834
Preliminary expenses (II)	0	0		Share premium, merger premium and contribution premium	277 106	277 106
				Retained earnings	-101 850	-67 586
Intangible assets	6 526	7 060		Profit/Loss for the period	-9 429	-34 264
Tangible assets	21 703	22 912		Investment subsidies	440	470
Financial assets	140 388	144 385		Total equity (I)	178 101	187 560
Total non-current assets (III)	168 616	174 357		Other equity (I-bis)	7 742	6 665
				Provisions (II)	1 378	769
Trade receivables and related accounts	3 363	3 122
Other receivables	3 132	2 465		Borrowings and similar liabilities	30 442	31 647
Prepaid expenses	315	611		Trade payable and related accounts	2 494	2 934
Marketable securities	7 866	9 034		Other liabilities	3 020	2 915
Cash and cash equivalents	39 646	42 630		Deferred income	0	0
Total current assets (IV)	54 323	57 861		Total liabilities (III)	35 956	37 495
Accruals and deferred income (V)	242	275		Accruals and deferred charges (IV)	4	4
TOTAL ASSETS (I + II + III + IV + V)	223 181	232 494		TOTAL EQUITY AND LIABILITIES (I + I-bis + II + III+ IV)	223 181	232 494

Carbios SA cash-flow statement:

Cash flow Statement (In thousands of euros)	06/30/2026	12/31/2025
Cash and cash equivalents at the beginning of the period	51 664	85 019
Cash flows related to operations	-7 119	-15 425
Cash flows related to investments	3 058(*)	-18 260
Net cash flow from financing activities	-90	330
Change in cash and cash equivalents	-4 151	-33 355
Cash and cash equivalents at end of period	47 513	51 664

(*): including €8 million from the partial repayment of a shareholder loan by Carbios 54 and €5 million related to investing activities.

---

1 Export credit agencies Bpifrance Assurance Export (France) and EIFO (Denmark) play a key role in supporting strategic projects, notably by providing partial guarantees to participating lending banks.
2 Refer to the Company’s press release published on July 21, 2026
3 Refer to the Company’s press release published on May 18, 2026

Attachment

• 2026 09 24 – PR Carbios – 2026 HY Results

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY TO ANY U.S. PERSON OR ANY

PERSON LOCATED IN THE UNITED STATES OF AMERICA OR IN ANY OTHER JURISDICTION WHERE IT IS

UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS PRESS RELEASE.

 

L’ORÉAL SUCCESSFULLY PRICES A 2 BILLION EURO TRIPLE TRANCHE BOND

 

Clichy, 24 September 2026 – L’Oréal today announces that it has successfully priced a bond offering for an aggregate nominal amount of €2 billion.

The offering is composed of three tranches:

– A €850 million 2-year floating rate bond paying a coupon of Euribor 3M + 27 bps p.a.

– A €500 million 3-year fixed rate bond paying a coupon of 3.75 % p.a.

– A €650 million 7-year fixed rate bond paying a coupon of 4.00 % p.a.

The net proceeds of the bond will be used for general corporate purposes.

The bond, which is expected to be rated AA (Stable) by S&P and Aa1 (Stable) by Moody’s, will be admitted to trading on Euronext Paris from the settlement date, which is scheduled to be 30 September 2026.

BNP Paribas, HSBC, and Société Générale are acting as Global Coordinators. Crédit Agricole CIB, Deutsche Bank, ING, Santander, and Standard Chartered Bank AG are acting as Active Joint Bookrunners.

About L’Oréal

For over 115 years, L’Oréal, the world’s leading beauty player, has devoted itself to one thing only: fulfilling the beauty aspirations of consumers around the world. Our purpose, to create the beauty that moves the world, defines our approach to beauty as essential, inclusive, ethical, generous and committed to social and environmental sustainability. With our broad portfolio of 40 international brands and ambitious sustainability commitments in our L’Oréal for the Future programme, we offer each and every person around the world the best in terms of quality, efficacy, safety, sincerity and responsibility, while celebrating beauty in its infinite plurality.

With more than 95,000 committed employees, a balanced geographical footprint and sales across all distribution networks (ecommerce, mass market, department stores, pharmacies, perfumeries, hair salons, branded and travel retail), in 2025 the Group generated sales amounting to 44.05 billion euros. With 22 research centers across 9 regional hubs around the world and a dedicated Research and Innovation team of over 4,000 scientists and more than 8,000 Digital, Tech and Data talents, L’Oréal is focused on inventing the future of beauty and becoming a Beauty Tech powerhouse.

In 2025, L’Oréal Groupe has been named the most innovative company in Europe by Fortune magazine, out of 300 companies, in a ranking spanning 21 countries and 16 industries in Europe.

More information on https://www.loreal.com/en/mediaroom

 

L’ORÉAL CONTACTS

Switchboard

+33 (0) 1 47 56 70 00

Individual shareholder relations

Angelique Fruchtenreich

+33 (0)1 47 56 45 35

angelique.fruchtenreich@loreal.com

Investor relations

Eva Quiroga

+33 (0)7 88 14 22 65

eva.quiroga@loreal.com

Journalists

Brune Diricq

+33 (0)6 63 85 29 87

brune.diricq@loreal.com

Christine Burke

+33 (0)6 75 54 38 15

christine.burke@loreal.com

For more information, please contact your bank, broker or financial institution (I.S.I.N. code: FR0000120321), and consult your usual newspapers, the website for shareholders and investors,

www.loreal-finance.com or the L’Oréal Finance app; alternatively, call +33 (0)1 40 14 80 50.

Follow us on LinkedIn @L’Oréal

Follow us on Instagram @lorealgroupe

www.loreal.com

Attachment

• LOREAL – EURO BOND issuance – september 2026 EN vfinal

OÜ Krulli Kodud, a joint venture between OÜ Merko Kodud, part of the AS Merko Ehitus group, and AS Krulli Kvartal, has decided to launch a new residential development at 1b Volta street in the Krulli Quarter. The project comprises three apartment buildings with a total of 23 apartments, scheduled for completion in early 2028.

Apartments in the Krulli homes (krullikodud.ee) range in size from 44 to 121 square metres, with prices starting from 6,600 euros per square metre. Each apartment has a balcony or terrace. Storage units and parking spaces are located on the underground parking level. The development will also include bicycle and pram storage facilities, as well as a shared hobby and leisure space for residents of the three buildings.

The Krulli development area covers 10 hectares, with more than 100,000 square metres of above-ground gross floor area planned. Over the next ten years, nearly 20 buildings are planned for the Krulli Quarter, comprising more than 600 homes and commercial premises providing workplaces for approximately 3,000 people. The buildings will be surrounded by a modern living environment.

The Volta 1b apartment buildings form part of the first development phase of the Krulli Quarter, which will also include an event centre, scheduled for completion in 2027, and the Kasvuhoone business and innovation centre, scheduled for completion in 2028. The first phase also includes the construction of the Bob W aparthotel and a mixed-use residential and commercial building, as well as the reconstruction of an existing commercial building.

Residential development projects in the Krulli Quarter are being developed by OÜ Krulli Kodud, a joint venture established in 2025 and owned equally by OÜ Merko Kodud and AS Krulli Kvartal. AS Merko Ehitus Eesti is the main contractor for the construction of the buildings in the quarter’s first development phase.

OÜ Merko Kodud (merko.ee/kodud) is Estonia’s best-known and most trusted residential real estate developer. To ensure the best quality, convenience and assurance for home buyers, Merko manages all phases of the development: planning, design, construction, sales and warranty service.

Additional information: CEO of OÜ Merko Kodud, Mr. Indrek Tarto, phone: +372 680 5105.

Urmas Somelar
Head of Finance
AS Merko Ehitus
+372 650 1250
urmas.somelar@merko.ee

AS Merko Ehitus (group.merko.ee) group companies construct buildings and infrastructure and develop real estate. We create a better living environment and build the future. We operate in Estonia, Latvia, and Lithuania. As at the end of 2025, the group employed 613 people, and the group’s revenue for 2025 was EUR 311 million.

Attachments

• Krulli kodud visualiseering-2
• Krulli kodud visualiseering-1

Amsterdam, 24 September 2026 (Regulated Information) — AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) has applied to list its shares on the Frankfurt Stock Exchange, with the first day of trading expected to be September 30, 2026.

As previously announced, AMG does not plan to issue or offer any new shares in connection with the secondary listing in Frankfurt. Euronext Amsterdam will continue to be AMG’s primary listing.

This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

This press release contains regulated information as defined in the Dutch Financial Markets Supervision Act (Wet op het financieel toezicht).

About AMG

AMG’s mission is to provide critical materials and related process technologies to advance a less carbon-intensive world. To this end, AMG is focused on the production and development of energy storage materials such as lithium, vanadium, and tantalum. In addition, AMG’s products include highly engineered systems to reduce CO₂ in aerospace engines, as well as critical materials addressing CO₂ reduction in a variety of other end use markets.

AMG’s Lithium segment spans the lithium value chain, reducing the CO₂ footprint of both suppliers and customers. AMG’s Vanadium segment is the world’s market leader in recycling vanadium from oil refining residues, spanning the Company’s vanadium, molybdenum, titanium, and chrome businesses. AMG’s Technologies segment is the established world market leader in advanced metallurgy and provides equipment engineering to the aerospace engine sector globally. It serves as the engineering home for the Company’s fast-growing LIVA batteries, NewMOX SAS formed to span the nuclear fuel market, and AMG’s mineral processing operations in antimony.

With approximately 3,500 employees, AMG operates globally with production facilities in Germany, the United Kingdom, France, the United States, China, Mexico, Brazil, and India, and has sales and customer service offices in Japan (www.amg-nv.com).

For further information, please contact:
AMG Critical Materials N.V.        +49 176 1000 73 14
Thomas Swoboda
tswoboda@amg-nv.com

Disclaimer

Certain statements in this press release are not historical facts and are “forward looking.” Forward looking statements include statements concerning AMG’s plans, expectations, projections, objectives, targets, goals, strategies, future events, future revenues or performance, capital expenditures, financing needs, plans and intentions relating to acquisitions, AMG’s competitive strengths and weaknesses, plans or goals relating to forecasted production, reserves, financial position and future operations and development, AMG’s business strategy and the trends AMG anticipates in the industries and the political and legal environment in which it operates and other information that is not historical information. When used in this press release, the words “expects,” “believes,” “anticipates,” “plans,” “may,” “will,” “should,” and similar expressions, and the negatives thereof, are intended to identify forward looking statements. By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, and risks exist that the predictions, forecasts, projections and other forward-looking statements will not be achieved. These forward-looking statements speak only as of the date of this press release. AMG expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained herein to reflect any change in AMG’s expectations with regard thereto or any change in events, conditions, or circumstances on which any forward-looking statement is based.

Attachment

• Dual Listing Filing Press Release

Geneva, Switzerland, September 24, 2026 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it will report its 2026 Half-Year and Second Quarter financial results on September 28, 2026. Tim Dyer, CEO and Mikhail Kalinichev, Head of Translational Science, will provide a business update and review of the Addex product pipeline during a teleconference and webcast for investors, analysts and media at 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) on September 28, 2026.

Title:  Addex Therapeutics Reports 2026 Half-Year and Second Quarter Financial Results and Provides Corporate Update
Date: September 28, 2026
Time: 16:00 CET (15:00 BST / 10:00 EDT / 07:00 PDT)

Joining the Conference Call:

1. Participants are required to register in advance of the conference using the link provided below. Upon registering, each participant will be provided with Participant Dial-in numbers, and a unique Personal PIN.
2. In the 10 minutes prior to the call start time, participants will need to use the conference access information provided in the e-mail received at the point of registering. Participants may also use the call me feature instead of dialing the nearest dial in number.

Webcast registration link: Registration webcast

Conference call registration link: Registration conference media

About Addex Therapeutics

Addex Therapeutics is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders. Addex’s lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is under evaluation for future development in brain injury recovery, including post-stroke and traumatic brain injury recovery. Addex’s partner, Indivior, has selected a GABAB PAM drug candidate for development in substance use disorders and has successfully completed IND enabling studies. Addex is advancing an independent GABAB PAM program for chronic cough. Addex holds a 20% equity interest in a private spin out company, Neurosterix US Holdings LLC, which is advancing a portfolio of allosteric modulator programs, including M4 PAM for schizophrenia, psychosis and mood-related disorders and mGlu7 NAM for mood disorders. In addition, Addex has invested in Stalicla, a private Swiss company pioneering a precision medicine approach for neurodevelopmental and neuropsychiatric disorders.

Addex shares are listed on the SIX Swiss Exchange and American Depositary Shares representing its shares are listed on the NASDAQ Capital Market, and trade under the ticker symbol “ADXN” on each exchange. For more information, visit www.addextherapeutics.com
  
Contacts: 

Tim Dyer  Chief Executive Officer  Telephone: +41 22 884 15 55  PR@addextherapeutics.com

Mike Sinclair  Partner, Halsin Partners  +44 (0)7968 022075  msinclair@halsin.com

Addex Forward Looking Statements:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements about the intended use of proceeds of the offering. The words “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release, are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, uncertainties related to market conditions. These and other risks and uncertainties are described in greater detail in the section entitled “Risk Factors” in Addex Therapeutics’ Annual Report on Form 20-F, prospectus and other filings that Addex Therapeutics may make with the SEC in the future. Any forward-looking statements contained in this press release represent Addex Therapeutics’ views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date. Addex Therapeutics explicitly disclaims any obligation to update any forward-looking statements.